Cargando…
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach
A personalized approach is strongly advocated for treatment selection in Multiple Sclerosis patients due to the high number of available drugs. Machine learning methods proved to be valuable tools in the context of precision medicine. In the present work, we applied machine learning methods to ident...
Autores principales: | Ferrè, Laura, Clarelli, Ferdinando, Pignolet, Beatrice, Mascia, Elisabetta, Frasca, Marco, Santoro, Silvia, Sorosina, Melissa, Bucciarelli, Florence, Moiola, Lucia, Martinelli, Vittorio, Comi, Giancarlo, Liblau, Roland, Filippi, Massimo, Valentini, Giorgio, Esposito, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861774/ https://www.ncbi.nlm.nih.gov/pubmed/36675783 http://dx.doi.org/10.3390/jpm13010122 |
Ejemplares similares
-
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2023) -
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction
por: Esposito, Federica, et al.
Publicado: (2015) -
Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2022) -
Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
por: Zanetta, Chiara, et al.
Publicado: (2023) -
BDNF Val66Met Polymorphism Is Associated With Motor Recovery After Rehabilitation in Progressive Multiple Sclerosis Patients
por: Giordano, Antonino, et al.
Publicado: (2022)